TETRALOGIC PHARMACEUTICALS CORP

Profile

Company Names

TETRALOGIC PHARMACEUTICALS CORP

Addresses

343 PHOENIXVILLE PIKE, MALVERN, PA 19355

Phone Numbers

610-889-9900

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$27,895,734.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2012-11-29 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Debt 
4
2011-05-20 
$5,999,734.00 
$5,999,734.00 
$0.00 
Equity 
3
2010-07-26 
$12,496,000.00 
$32,000,000.00 
$19,504,000.00 
Equity 
2
2010-03-11 
$2,400,000.00 
$2,400,000.00 
$0.00 
Debt 
1
2009-11-25 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRENDA 
 
GAVIN 
DIRECTOR
DIASOME PHARMACEUTICALS LLC   |  TETRALOGIC PHARMACEUTICALS CORP   |  BIOLEAP, INC.
JOHN 
M. 
GILL 
EXECUTIVE OFFICER, DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP
JAMES 
E. 
GOLDSCHMIDT 
EXECUTIVE OFFICER
TETRALOGIC PHARMACEUTICALS CORP
HELGA 
 
KAUTSKY 
EXECUTIVE OFFICER
TETRALOGIC PHARMACEUTICALS CORP   |  DIASOME PHARMACEUTICALS, INC.
JACK 
 
LASERSOHN 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  SILK ROAD MEDICAL INC   |  ONCOMED PHARMACEUTICALS INC   |  ROUTE 92 MEDICAL, INC.   |  AIS VGP-6, LLC   |  EL CAMINO REAL MEDICAL, INC.   |  HIGHWAY 1 MEDICAL, INC.
MARK 
A. 
MCKINLAY 
EXECUTIVE OFFICER
TETRALOGIC PHARMACEUTICALS CORP
GEORGE 
 
MCLENDON 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  BRAINCHECK, INC.   |  SENSORRX, INC.
DOUGLAS 
 
ONSI 
DIRECTOR
SEQUOIA PHARMACEUTICALS INC   |  ANEXON, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  LEAP THERAPEUTICS, INC.
ANDREW 
 
PECORA 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  CANCER GENETICS INC   |  AMORCYTE INC   |  CELULARITY INC.   |  COTA, INC.   |  THIRD WAVE RECOVERY SYSTEMS, LLC
DOUGLAS 
 
REED 
DIRECTOR
SPINEWORKS MEDICAL INC   |  SPINEALIGN MEDICAL INC   |  VIAMET PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  HATTERAS VENTURE PARTNERS IV, LP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  NEUROTRONIK, INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  COFERON, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  BLINKBIO, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  QPEX BIOPHARMA, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  EMX ROYALTY CORP   |  AVIVOMED INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
PAUL 
 
SCHMITT 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  CERNOSTICS, INC.   |  BELLROCK INTELLIGENCE, INC.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2017   |  ENVIROLASTECH, INC.   |  PERFORMANCE EFFEM PE FUND, L.P. - SERIES 2018   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2019   |  SURGEONCHECK LLC   |  PERFORMANCE EQUITY GROWTH OPPORTUNITIES FUND, L.P.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2021   |  PERFORMANCE REGENT 2021 OVERAGE FUND, L.P.   |  PERFORMANCE REGENT 2021 CORE FUND, L.P.   |  PERFORMANCE IOOF CO-INVESTMENT FUND, L.P.   |  PERFORMANCE VENTURE CAPITAL V, L.P.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2022   |  PERFORMANCE GCP CO-INVESTMENT, L.P.   |  PERFORMANCE VENTURE CAPITAL VI, L.P.   |  PERFORMANCE VENTURE CAPITAL VI FEEDER, L.P.   |  PVC SPECIAL OPPORTUNITIES FUND I, L.P.
MICHAEL 
 
STEINMETZ 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  MACROGENICS INC   |  ALLOZYNE INC   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.
DAVID 
E. 
WENG 
EXECUTIVE OFFICER
TETRALOGIC PHARMACEUTICALS CORP
HAROLD 
 
WERNER 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  STEMGENT, INC.   |  INFACARE PHARMACEUTICAL CORP
JAMES 
 
WOODY 
DIRECTOR
CELL BIOSCIENCES INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  NEURALTUS PHARMACEUTICALS, INC.   |  HEMAQUEST PHARMACEUTICALS, INC.   |  PERCEPTIMED, INC.   |  VIRACTA THERAPEUTICS, INC.
JIM 
 
WOODY 
DIRECTOR
FEMTA PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  ONCOMED PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-12-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-29 
2011-05-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
2010-08-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-26 
2010-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-11 
2010-03-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-25 
2010-03-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-11-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#